Steven St. Peter
2017
In 2017, Steven St. Peter earned a total compensation of $2.8M as President and CEO at Aratana Therapeutics, a 112% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $213,000 |
|---|---|
| Option Awards | $982,434 |
| Salary | $513,000 |
| Stock Awards | $1,121,998 |
| Other | $10,800 |
| Total | $2,841,232 |
Peter received $1.1M in stock awards, accounting for 39% of the total pay in 2017.
Peter also received $213K in non-equity incentive plan, $982.4K in option awards, $513K in salary and $10.8K in other compensation.
Rankings
In 2017, Steven St. Peter's compensation ranked 3,845th out of 14,666 executives tracked by ExecPay. In other words, Peter earned more than 73.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,845 out of 14,666 | 74th |
Division Manufacturing | 1,345 out of 5,772 | 77th |
Major group Chemicals And Allied Products | 380 out of 2,075 | 82nd |
Industry group Drugs | 294 out of 1,731 | 83rd |
Industry Pharmaceutical Preparations | 234 out of 1,333 | 82nd |
Source: SEC filing on June 8, 2018.
Peter's colleagues
We found three more compensation records of executives who worked with Steven St. Peter at Aratana Therapeutics in 2017.